Entrada Therapeutics, Inc.
TRDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44 | -$43 | -$17 | $1 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5 | $5 | $5 |
| Change in WC | $10 | $8 | -$26 | -$36 |
| Other Non-Cash | $4 | -$1 | -$1 | -$3 |
| Operating Cash Flow | -$28 | -$29 | -$39 | -$32 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$27 | -$17 | -$80 | -$64 |
| Inv. Sales/Matur. | $76 | $51 | $86 | $118 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $49 | $34 | $5 | $53 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $0 | $0 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $21 | $5 | -$33 | $23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72 | $72 | $105 | $82 |
| End Cash | $93 | $76 | $72 | $105 |
| Free Cash Flow | -$28 | -$30 | -$40 | -$32 |